Provided by Tiger Trade Technology Pte. Ltd.

Sequoia Capital Holdings

3,360.99
+33.641.01%
Number of Gainers:76
Number of Losers:23
Number of Flat:1
PE:- -
High:3,376.19
Open:3,327.94
Low:3,327.94
Close:3,327.35
Volume:986.69M
Turnover:216.41B
Market Cap:44.14T
Float Cap:41.22T

Loading ...

Home Depot Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Brookfield Infrastructure Partners L.P. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Sep 09

Travel + Leisure CFO Erik Hoag to Speak at Goldman Sachs Consumer, Retail Conference

Reuters
·
Sep 09

Warby Parker to Present at Goldman Sachs Global Retailing Conference

Reuters
·
Sep 09

Asia Morning Call-Global Markets

Reuters
·
Sep 09

AMD, Amgen, Novartis, Qualcomn, Corning, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 09

PVH CEO, CFO to Join Goldman Sachs Global Retailing Conference Fireside Chat

Reuters
·
Sep 09

AT&T CEO John Stankey Speaks at Goldman Sachs Communacopia + Technology Conference

Reuters
·
Sep 09

US Equity Markets End Lower After Houthi Attack on Saudi Arabia Energy Facilities

MT Newswires Live
·
Sep 09

US Stocks Fall as Dow Drops 600 Points, Philadelphia Semiconductor Index Bucks Trend Up 1.3%; Semiconductor Stocks Strengthen, Intel Rises 9%, SK Hynix Gains Nearly 5%

TradingKey
·
Sep 09

John Stankey to Update Shareholders at Goldman Sachs Communacopia + Technology Conference on September 9

THOMSON REUTERS
·
Sep 09

Cboe data suggests bullish flow in Alphabet with shareslittle changed

TIPRANKS
·
Sep 09

Market Chatter: Apple to Debut Foldable iPhone Ultra, iPhone 18 Pro at the Upcoming 'Surprise and Shine' Event

MT Newswires Live
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS
·
Sep 09

Cboe data shows mixed options sentiment in Apple with shares down 1.2%

TIPRANKS
·
Sep 09

3 ETFs Ready for the High-Yield Dividend Stress Test

Dow Jones
·
Sep 09